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The mammalian target of rapamycin complex 1 (mTORC1), which promotes cell growth, is regulated 
by specific nutrients such as the amino acid leucine. In this issue, Nicklin et al. (2009) describe a 
mechanism by which glutamine facilitates the uptake of leucine, leading to mTORC1 activation.The target of rapamycin complex 1 
(TORC1) is a highly conserved serine/
threonine kinase that in mammals acti-
vates cell growth in response to nutri-
ents (amino acids), growth factors (such 
as insulin and insulin-like growth fac-
tor), and cellular energy status (ATP) (for 
review, see Wullschleger et al., 2006). 
Although the signaling cascades lead-
ing from growth factors and energy 
to mTORC1 activation are known, the 
pathway that leads from amino acids to 
mTORC1 activation is less clear. Nick-
lin et al. (2009) now close a gap in our 
understanding of this pathway by iden-
tifying amino acid transporters that act 
upstream of mTORC1.
Multiple pathways converge on 
mTORC1, making it a focal point for the 
control of cell growth. Insulin and other 
growth factors activate mTORC1 by 
inhibiting the tuberous sclerosis complex 
(TSC1-TSC2) downstream of AKT (also 
known as PKB) (Figure 1). TSC1-TSC2 
is a GTPase-activating protein (GAP) for 
the small GTPase Rheb, the direct acti-
vator of mTORC1. Conversely, mTORC1 
activity is decreased in response to a 
reduction in ATP levels because of the 
activation of adenosine monophosphate figure 1. mTORc1 Activation by Glutamine-Dependent Leucine Uptake
(A) Glutamine (Gln) is transported into cells in a sodium (Na+) dependent manner through SLC1A5 (green). 
Glutamine in turn is used to import leucine (Leu) via the antiporter SLC7A5-SLC3A2 (purple). Intracellular 
leucine is sensed by an unknown factor that activates mammalian TOR complex 1 (mTORC1) through 
the Rag GTPases or through an unknown pathway. Growth factors activate mTORC1 through the PI3K-
PDK1-AKT-TSC1/2-Rheb pathway. mTORC1 is activated in the presence of amino acids, growth factors, 
and energy (not shown). 
(B) When cells are starved for glutamine, leucine cannot be transported into cells. As a result, mTORC1 
is not activated, even in the presence of growth factors.Cell 136or D), which deliver mTORC1 to GTP-
loaded Rheb (Kim et al., 2008; Sancak 
et al., 2008).
Amino acid availability, in particular 
the availability of the essential amino 
acids leucine and arginine, is required 
for mTORC1 activation (for review, see 
Avruch et al., 2008). The absence of leu-
cine or arginine prevents mTORC1 acti-activated protein kinase (AMPK), which 
phosphorylates and activates TSC1-
TSC2. However, not all pathways for 
mTORC1 activation go through TSC1-
TSC2. AMPK also phosphorylates and 
inactivates mTORC1 directly. It has also 
been recently shown that amino acids 
signal to mTORC1 through heterodimers 
of Rag GTPases (RagA or B and RagC , February 6, 2009 ©2009 Elsevier Inc. 399
vation, and removal of either one causes 
rapid dephosphorylation of the well-
characterized mTORC1 substrates S6 
kinase (S6K) and the translation inhibitor 
4E-BP. As shown in Xenopus oocytes, 
which lack amino acid transporters, 
extracellular leucine fails to activate 
TORC1. However, leucine can activate 
TORC1 in oocytes expressing system L 
amino acid transporters or in oocytes 
where this amino acid is injected directly 
into the cytoplasm (Christie et al., 2002). 
Intriguingly, it has been suggested that 
glutamine has a secondary but otherwise 
poorly understood role in the activation 
of mTORC1 in mammalian cells (Krause 
et al., 2002). Despite the importance of 
particular amino acids in the regulation 
of cell growth, it has been unclear how 
leucine enters cells to activate mTORC1 
and what role glutamine has in this pro-
cess.
Using S6K1 and 4E-BP phosphoryla-
tion as a readout for mTORC1 activity, 
Nicklin et al. (2009) show that mTORC1 
activation in response to leucine requires 
preloading of cells with glutamine. Glu-
tamine alone has no effect on mTORC1, 
but it must be present in cells before 
external leucine can have any effect on 
mTORC1. Using pharmacological inhibi-
tors and short-interfering RNAs (siRNAs), 
the authors demonstrate that glutamine 
uptake requires SLC1A5, a high-affinity 
transporter for neutral amino acids that 
lack branched side chains (Fuchs and 
Bode, 2005). If SLC1A5 is inhibited dur-
ing the incubation of cells with glutamine, 
subsequent incubation of cells with leu-
cine has no effect on mTORC1 activity. 
Thus, glutamine is upstream of leucine in 
the activation of mTORC1. The authors 
further show that glutamine metabolites, 
including amino acids synthesized from 
glutamine, cannot substitute for glu-
tamine in mTORC1 activation, indicating 
that it is glutamine itself that is required.
How does glutamine act upstream 
of leucine? The authors show that the 
transporter that imports leucine to regu-
late mTORC1 is a heterodimeric system 
L amino acid transporter called SLC7A5-
SLC3A2. Importantly, SLC7A5-SLC3A2 
is an antiporter that imports branched 
amino acids such as leucine while export-400 Cell 136, February 6, 2009 ©2009 Elseving glutamine (Fuchs and Bode, 2005). 
Using pharmacological inhibitors and siR-
NAs, the authors show that inhibition of 
SLC7A5-SLC3A2 prevents mTORC1 acti-
vation by glutamine and leucine without 
affecting glutamine uptake. Analysis of 
the composition of tissue culture medium 
from growing cells, as well as experi-
ments using stable glutamine and leucine 
isotopes, demonstrates that glutamine 
is indeed released from glutamine pre-
loaded cells when incubated with leucine. 
Furthermore, under the authors’ experi-
mental conditions, the uptake of leucine 
correlates with rapid S6K1 phosphoryla-
tion. Thus, glutamine acts upstream of 
leucine as an efflux solute allowing the 
influx of leucine through the SLC7A5-
SLC3A2 antiporter (Figure 1).
Nicklin et al. also examined the 
involvement of the glutamine and leucine 
transporters in physiological processes 
regulated by mTORC1, in particular 
cell growth and autophagy. Reduced 
transport of glutamine or leucine due 
to knockdown of SLC1A5 or SLC7A5-
SLC3A2 expression, respectively, 
causes a marked reduction in cell size. 
Knockdown of the expression of SLC1A5 
or an absence of glutamine also induces 
autophagy. Thus, the two transporters 
appear to be physiologically relevant 
activators of mTORC1.
Nicklin et al. provide important new 
insight into the molecular mechanism 
by which glutamine and leucine sig-
nal to mTORC1. However, many ques-
tions remain. What are the transporters 
for the amino acids other than leucine 
and glutamine that influence mTORC1 
activity? Do sequestered intracellular 
pools of amino acids, such as those in 
the lysosome, regulate mTORC1 activity 
and what is the role of intracellular amino 
acid transporters? mTORC1 activity 
enhances surface expression of amino 
acid transporters in response to nutrients 
(Edinger and Thompson, 2002). Does a 
positive feedback loop involving amino 
acid transporters regulate mTORC1 in a 
physiologically relevant manner? Impor-
tantly, does intracellular leucine activate 
mTORC1 via the Rag GTPases? What 
are the intracellular sensors for leucine 
and other amino acids? Are these sen-ier Inc.sors specific to each amino acid or are 
they more general? Lastly, the kinase 
MAP4K3, the proposed mTORC1 inhibi-
tor FKBP38, and the type III phospho-
inositide 3-kinase hVPS34 have also 
been implicated in the regulation of 
mTORC1 activity in response to amino 
acids (Avruch et al., 2008). What is the 
relationship between these proteins and 
SLC7A5-SLC3A2-mediated activation of 
mTORC1?
These findings may also have impli-
cations for cancer. Tumor cells engage 
in glutamine metabolism exceeding the 
need for glutamine as a biosynthetic 
precursor. It has been suggested that 
glutamine is used to produce NADPH 
(nicotinamide adenine dinucleotide phos-
phate) to support anabolic processes 
necessary for oncogenic growth (DeBe-
rardinis et al., 2007). Although activation 
of mTORC1 does not require glutamine 
metabolism, the results from Nicklin et 
al. suggest that glutamine could also 
drive tumor growth through activation of 
mTORC1.
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